Endpoints News | Jazz vaults into the cannabinoid field with $7.2B GW Pharma buyout


GW Pharma $GWPH, the UK biotech that caused a sensation of sorts with the approval of the world’s first cannabinoid med, is being bought out.

Jazz Pharmaceuticals came up with the winning number, agreeing to acquire GW for a total of $7.2 billion — $6.7 billion net of cash. GW agreed to a price of $200 cash and $20 in stock for the acquisition. This is the second biotech M&A deal of the week, which will likely portend more such deals to come.’

Click through to read the full article on Endpoints News here.

91 replies

Trackbacks & Pingbacks

  1. gay chat am says:

    good chat to meet gay men are bi https://gaychatcams.net/

  2. online casino with free signup bonus real money usa no deposit https://online2casino.com/

Comments are closed.